Rezolute (RZLT) News Today → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free RZLT Stock Alerts $2.56 -0.09 (-3.40%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 7:58 PM | markets.businessinsider.comBuy Rating Affirmed for Rezolute Amidst Clinical Progress and Market OpportunityMay 16 at 2:57 PM | finanznachrichten.deRezolute, Inc.: Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business UpdateMay 16 at 12:39 PM | marketbeat.comRezolute's (RZLT) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $14.00 price objective on shares of Rezolute in a research note on Thursday.May 16 at 12:06 AM | investorplace.comRZLT Stock Earnings: Rezolute Misses EPS for Q3 2024May 15 at 4:05 PM | globenewswire.comRezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business UpdateMay 12, 2024 | nasdaq.comRezolute, Inc. Common Stock (NV) (RZLT) NewsMay 10, 2024 | finance.yahoo.comRezolute, Inc. (NASDAQ:RZLT) has caught the attention of institutional investors who hold a sizeable 47% stakeMay 9, 2024 | marketbeat.comVivo Capital LLC Raises Position in Rezolute, Inc. (NASDAQ:RZLT)Vivo Capital LLC increased its stake in Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 569.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,242,842 shares of the company's stock after purchasing an additional 2,758,403 shApril 27, 2024 | marketbeat.comVivo Capital LLC Has $7.13 Million Position in Rezolute, Inc. (NASDAQ:RZLT)Vivo Capital LLC trimmed its position in Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 13.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,797,704 shares of the company's stockApril 24, 2024 | marketbeat.comFederated Hermes Inc. Purchases 3,544,053 Shares of Rezolute, Inc. (NASDAQ:RZLT)Federated Hermes Inc. raised its holdings in shares of Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 53.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,154,327 shares of the company's stock after purApril 23, 2024 | globenewswire.comPhase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual MeetingApril 19, 2024 | msn.comJonesTrading Initiates Coverage of Rezolute (RZLT) with Buy RecommendationApril 18, 2024 | marketbeat.comRezolute (NASDAQ:RZLT) Given Market Outperform Rating at JMP SecuritiesJMP Securities reiterated a "market outperform" rating and issued a $7.00 price target on shares of Rezolute in a research note on Thursday.April 18, 2024 | marketbeat.comJonestrading Begins Coverage on Rezolute (NASDAQ:RZLT)Jonestrading initiated coverage on shares of Rezolute in a research note on Thursday. They issued a "buy" rating and a $10.00 price target for the company.April 18, 2024 | markets.businessinsider.comOptimistic Buy Rating for Rezolute’s RZ402 Drug Candidate Amid Promising DME Treatment ProspectsApril 15, 2024 | investorplace.comCan You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?April 10, 2024 | benzinga.comRezolute Stock (NASDAQ:RZLT), Analyst Ratings, Price Targets, PredictionsApril 9, 2024 | marketbeat.comRezolute (NASDAQ:RZLT) Earns Buy Rating from Analysts at Maxim GroupMaxim Group assumed coverage on Rezolute in a report on Tuesday. They issued a "buy" rating and a $8.00 price target on the stock.April 4, 2024 | insidermonkey.comInsiders Are Buying These 5 Penny StocksMarch 27, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) Short Interest UpdateRezolute, Inc. (NASDAQ:RZLT - Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 214,700 shares, a drop of 88.2% from the February 29th total of 1,820,000 shares. Based on an average daily trading volume, of 287,300 shares, the days-to-cover ratio is presently 0.7 days.March 27, 2024 | finance.yahoo.comRezolute Reaches US$75m Market Cap Benefiting Insider Stock BuyingMarch 26, 2024 | insidertrades.com3 Stocks Insiders Are Buying That Analysts Love (RZLT)March 20, 2024 | investing.comRezolute's chief medical officer buys $18.8k in company stockMarch 20, 2024 | insidertrades.comDaron Evans Buys 20,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) StockMarch 19, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) CFO Daron Evans Acquires 20,000 SharesRezolute, Inc. (NASDAQ:RZLT - Get Free Report) CFO Daron Evans purchased 20,000 shares of the firm's stock in a transaction dated Friday, March 15th. The stock was acquired at an average cost of $1.69 per share, with a total value of $33,800.00. Following the purchase, the chief financial officer now owns 20,000 shares of the company's stock, valued at approximately $33,800. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.March 19, 2024 | insidertrades.comBrian Kenneth Roberts Acquires 10,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) StockMarch 18, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) Insider Brian Kenneth Roberts Buys 10,000 SharesRezolute, Inc. (NASDAQ:RZLT - Get Free Report) insider Brian Kenneth Roberts acquired 10,000 shares of the business's stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average price of $1.88 per share, for a total transaction of $18,800.00. Following the completion of the transaction, the insider now owns 10,000 shares in the company, valued at $18,800. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.March 15, 2024 | insidertrades.comInsider Buying: Rezolute, Inc. (NASDAQ:RZLT) Director Buys 36,503 Shares of StockMarch 14, 2024 | marketbeat.comInsider Buying: Rezolute, Inc. (NASDAQ:RZLT) Director Purchases 36,503 Shares of StockRezolute, Inc. (NASDAQ:RZLT - Get Free Report) Director Young-Jin Kim acquired 36,503 shares of the business's stock in a transaction on Thursday, March 7th. The shares were purchased at an average price of $1.91 per share, with a total value of $69,720.73. Following the transaction, the director now owns 115,450 shares in the company, valued at approximately $220,509.50. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.March 13, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) Sees Significant Growth in Short InterestRezolute, Inc. (NASDAQ:RZLT - Get Free Report) was the target of a significant growth in short interest in February. As of February 29th, there was short interest totalling 1,820,000 shares, a growth of 80.2% from the February 14th total of 1,010,000 shares. Based on an average daily volume of 268,300 shares, the days-to-cover ratio is currently 6.8 days.March 11, 2024 | insidertrades.comRezolute, Inc. (NASDAQ:RZLT) CFO Acquires $96,500.00 in StockMarch 8, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) CFO Buys $96,500.00 in StockRezolute, Inc. (NASDAQ:RZLT - Get Free Report) CFO Daron Evans bought 50,000 shares of the business's stock in a transaction on Friday, March 8th. The shares were acquired at an average price of $1.93 per share, with a total value of $96,500.00. Following the transaction, the chief financial officer now directly owns 120,900 shares of the company's stock, valued at $233,337. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.March 7, 2024 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Rezolute (NASDAQ:RZLT)HC Wainwright reissued a "buy" rating and issued a $14.00 price objective on shares of Rezolute in a research report on Thursday.March 6, 2024 | globenewswire.comRezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)February 27, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) Insider Brian Kenneth Roberts Acquires 6,000 SharesRezolute, Inc. (NASDAQ:RZLT - Get Free Report) insider Brian Kenneth Roberts purchased 6,000 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was purchased at an average cost of $1.69 per share, with a total value of $10,140.00. Following the purchase, the insider now owns 40,552 shares in the company, valued at approximately $68,532.88. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.February 22, 2024 | benzinga.comRezolute Stock (NASDAQ:RZLT) Earnings Dates and Earning CallsFebruary 20, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) CFO Daron Evans Buys 41,900 SharesRezolute, Inc. (NASDAQ:RZLT - Get Free Report) CFO Daron Evans purchased 41,900 shares of the business's stock in a transaction on Friday, February 16th. The shares were bought at an average cost of $1.30 per share, for a total transaction of $54,470.00. Following the purchase, the chief financial officer now owns 70,900 shares of the company's stock, valued at $92,170. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink.February 16, 2024 | finanznachrichten.deRezolute, Inc.: Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateFebruary 15, 2024 | finance.yahoo.comWe're Keeping An Eye On Rezolute's (NASDAQ:RZLT) Cash Burn RateFebruary 13, 2024 | finance.yahoo.comRezolute Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateFebruary 8, 2024 | markets.businessinsider.comBuy Rating Affirmed for Rezolute’s RZ358 Based on Untapped Market Potential and Therapeutic EfficacyJanuary 24, 2024 | msn.comRezolute appoints Daron Evans as CFOJanuary 23, 2024 | msn.comRezolute secures innovation passport designation from U.K. for RZ358 treating hypoglycemiaJanuary 23, 2024 | finance.yahoo.comRezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital HyperinsulinismDecember 14, 2023 | finance.yahoo.comRezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital HyperinsulinismDecember 13, 2023 | finance.yahoo.comRezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)November 28, 2023 | msn.comRezolute (RZLT) Price Target Increased by 5.77% to 8.42November 24, 2023 | finanznachrichten.deRezolute, Inc.: Rezolute Reports First Quarter Fiscal 2024 ResultsNovember 18, 2023 | markets.businessinsider.comRezolute’s Promising Drug Pipeline and Market Position Validate Buy Rating: An Analysis of RZ358 and RZ402 PotentialNovember 17, 2023 | finance.yahoo.comRezolute to Participate in BTIG’s 3rd Annual Ophthalmology Day Get Rezolute News Delivered to You Automatically Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter. Email Address “Dollar Will Be Worth NOTHING” -Musk (Ad)Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher. Click here to claim your free seat ticket now. RZLT Media Mentions By Week RZLT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RZLT News Sentiment▼0.270.55▲Average Medical News Sentiment RZLT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RZLT Articles This Week▼101▲RZLT Articles Average Week Get Rezolute News Delivered to You Automatically Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RLMD News SCTL News OPTN News CLRB News PMVP News COYA News CTXR News ALLK News RNAC News IMUX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RZLT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsWhy Is Gold On a MASSIVE rally? Huge AlertsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rezolute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
